Page 27 - IJB-3-1
P. 27

William Whitford and James B. Hoying

            ing materials, accommodating (or ameliorating) heig-  tion or topology of the microvessels in the perfusion
            htened leachables contamination as well as sorption of   network impacts overall  performance [27] . Thus, the
            lipophilic vitamins or lipids may be considered.   incorporation of a vascular supply into a manufactured
                                                               tissue construct must address the formation of each of
            4.4 Application-specific Factors                   the numerous, complex individual microvessels  and

            Depending upon the  application, a number of addi-  their integration into a perfusion circuit [28]  matched to
            tional manufacturing aspects  may need to be consi-  the needs of the tissue parenchyma.
            dered.  For  tissues, tissue-mimics or other structures   4.6 Angiogenesis and Vasculogenesis
            related  to  either cell  and tissue  therapies or in IVD
            applications, the quality and regulatory implications of   New microvessels arise from either angiogenic sprouts
            the bioink must be examined, as has been begun for   of existing, parent microvessels or the de novo assem-
            printed medical devices [24] . For these applications es-  bly of vascular cells into the microvessels called vas-
            pecially,  the  nature  and number of  particulates  from   culogenesis [27] . A variety of cell types and strategies
            the disposable components of the printing  path cou-  have been employed  to derive  microvessels. These
            ld be significant. The composition of biopapers, or a   include the use of endothelial cells, both macrovascu-
            matrix upon which the ink is applied during printing,   lar and microvascular, endothelial progenitor cells
            is another consideration in some applications. An in-  (EPCs), perivascular cell  precursors,  mesenchymal
            teresting new development for applications employing   and hematopoietic stem cells (MSCs and HSCs), and
            human pluripotent stem cells is the announcement by   smooth  muscle  cells incorporated  into the  construct
            GE Healthcare that a serum-derived protein supple-  either alone or in combination. Adipose stromal vas-
            ment in a completely defined, xeno-free medium can   cular fraction (SVF) cells  show  particularly robust
            support stable culture of human pluripotent stem cells   vasculogenic activity, perhaps because all of the cell
            on untreated matrix [25] .                         types  necessary to forming  microvasculatures are
                                                               present within the  isolate [20,29] . Angiogenesis-based
            4.5 Vascularization                                strategies include pre-packaging endothelial  cells in
                                                               clusters or aggregates, from which neovessels
            The importance of including a vascular component in     [30]
            digitally  biomanufactured tissue  constructs as both  a   sprout  , or the use of intact microvessel fragments as
                                                               a source  of parent microvessels from  which neoves-
            means to provide perfusion to a tissue and impart re-  sels arise via angiogenesis [28] .
            levant functionality (as the vasculature  also contri-
            butes to tissue function) is well appreciated. The abil-  4.7 Post Printing Cues
            ity to establish and maintain a functional microcircu-
            lation  in vitro  significantly impacts a  broad array   In all cases, the newly formed microvessels (or neo-
            of biomedical arenas [21,22] . In virtually every discus-  vessels) are immature in form and function, requiring
                                                                                                          [31]
            sion concerning  the building of  tissue  replacements,   hemodynamic cues to drive subsequent maturation  .
            the  critical  importance of having  a microvasculature   This vascular maturation, of both the individual neo-
            integrated into the tissue construct is stressed [23–25] . In   vessels and network, depends on substantial remode-
            cellular assay platforms,  the  presence of  a perfused   ling and adaptation activities, as the neovessels speci-
            vasculature in combination with the target parenchy-  fy into arterioles, capillaries, and venules and integrate
            ma cell is considered to improve the utility of the as-  into  a contiguous network. Therefore,  consideration
            say beyond having just parenchyma cells [26] . Signifi-  of bioinks amenable to successful fabrication of vas-
            cantly, the smaller elements of the vasculature, the   culatures in a digital biomanufacturing process should
            microvasculature, pose unique challenges in a bioma-  support not only vascular cell viability, but also pro-
            nufacturing  process. A stereotypical microvessel is   mote individual neovessel assembly and permit adap-
            comprised of  multiple cell types (endothelial cells,   tation to a mature microvasculature.
            smooth  muscle/contractile cells, perivascular  mesen-  5. Vascular Compatible Bioinks
            chymal cells, and immune cells) assembled in a very
            structured way critical to the microvessel’s function [26] .   Nearly all the bioinks used with  non-vascular cells
            In addition, many individual microvessels are needed   will also support vascular cells. Furthermore, leverag-
            (perhaps thousands in some applications) to assemble   ing  the  potent  self-assembly capabilities intrinsic  to
            and effective perfusion circuit. Finally, the organiza-  vascular cells, these bioinks readily enable formation

                                        International Journal of Bioprinting (2017)–Volume 3, Issue 1      23
   22   23   24   25   26   27   28   29   30   31   32